FDA · United States
diethylpropion hydrochloride — FDA regulatory status
diethylpropion hydrochloride (TENUATE) regulatory status in the United States is tracked from public FDA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: FDA approved.
Status snapshot
- Status
- FDA approved
- Brand
- TENUATE
- Originator
- Teva Pharma GmbH
- Mechanism
- Norepinephrine transporter inhibitor
- Target
- Sodium-dependent dopamine transporter
- Structured fields
- 8
Sponsor / originator context: Teva Pharma GmbH. Pipeline programs and exclusivity signals below are joined from ClinicalTrials.gov-linked projects and USPTO/EPO patent rows associated with this INN.
Pharmacology context used for competitive intelligence: Norepinephrine transporter inhibitor. Target: Sodium-dependent dopamine transporter. This page is a status aggregation for professional reference — not prescribing advice.
Regional decision snapshot — FDA: approved.
Linked evidence on this spoke: 20 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| FDA | United States | approved | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| CYD32 | Phase 3 | Sanofi Pasteur MSD | NCT01254422 |
| DEN-303 | Phase 3 | Takeda | NCT03999996 |
| Investigational live attenuated mumps vaccine | Phase 3 | Sinovac Research and | NCT02692599, NCT05065177 |
| Live attenuated Japanese encephalitis chimeric virus vaccine | Phase 3 | Sanofi Pasteur MSD | NCT01396512 |
| Live attenuated SA 14-14-2 vaccine | Phase 3 | Repatha | NCT00412516 |
| Live-Attenuated influenza Vaccine(LAIV) | Phase 3 | BRIGHT MINDS BIOSCIENCES | NCT02964065 |
| Metalyse 5 000 units (25 mg) powder for solution for injection | Phase 3 | PARItec | 2024-520414-21-00 |
| Oka strain varicella attenuated live vaccine | Phase 3 | Chinese Academy of | NCT06614816 |
| PRO-VZV-4002 | Phase 3 | Sinovac Research and | NCT05015686 |
| VAD00004 | Phase 3 | Sanofi-Aventis U.S | 2023-505762-29-00 |
| Dose-attenuated IST and Hetrombopag | Phase 2 | Chinese Academy of | NCT07010237 |
| Durability of protection after single immunis... for Falciparum malaria | Phase 2 | Disc Medicine | 2024-513516-99-00 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12409213 | Live attenuated oral vaccine against shigellosis and typhoid fever | US |
| 12383566 | Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity | US |
| 12102671 | Method of vaccination with an attenuated RSV vaccine formulation | US |
| 12054519 | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes | US |
| 11813319 | Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L | US |
| 11801296 | Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R | US |
| 11793870 | Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof | US |
| 11730801 | Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof | US |
| 11478517 | Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof | US |
| 11331383 | Attenuated african swine fever virus vaccine | US |
| 11318196 | Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein | US |
| 11202825 | Attenuated infectious bronchitis virus | US |
Related hubs
FAQ
What is the FDA approval status of diethylpropion hydrochloride?
diethylpropion hydrochloride currently shows FDA approved in our United States regulatory index. Confirm on the official FDA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get diethylpropion hydrochloride regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to diethylpropion hydrochloride?
This spoke lists 20 published programs associated with diethylpropion hydrochloride in our pipeline index.